Floatz logo

Nano-Crystalline Megestrol Acetate Suspension

Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment

Changchun GeneScience Pharmaceutical Co., Ltd.N/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment cohort.

Asset / SponsorPhaseRating
MEGESTROL ACETATE IMPURITY B
Changchun GeneScience Pharmaceutical Co., Ltd.
N/AD

Same molecule, other indications

Nano-Crystalline Megestrol Acetate Suspension is also rated in:

Untreated With Systemic TherapyDormant
B
Indicative ·
60 / 100
View asset →
small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →
The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative TherapyDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →